First experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis
https://doi.org/10.15829/1560-4071-2020-3847
Abstract
About the Authors
A. V. Bogachev-ProkofievRussian Federation
Novosibirsk
R. M. Sharifulin
Russian Federation
Novosibirsk
M. A. Ovcharov
Russian Federation
Novosibirsk
A. N. Pivkin
Russian Federation
Novosibirsk
O. V. Krestyaninov
Russian Federation
Novosibirsk
T. V. Antropova
Russian Federation
Novosibirsk
M. A. Ovchinnikova
Russian Federation
Novosibirsk
D. A. Astapov
Russian Federation
Novosibirsk
A. V. Sapegin
Russian Federation
Novosibirsk
A. V. Afanasyev
Russian Federation
Novosibirsk
S. A. Budagaev
Russian Federation
Novosibirsk
S. I. Zheleznev
Russian Federation
Novosibirsk
References
1. Bockeria LA, Klimchuk JI. Insufficiency of the mitral valve in patients with atrial fibrillation. Current state of the problem, approach to diagnostics and complex surgical treatment. Annals of Arrhythmology. 2015;12:4. (In Russ.) doi:10.15275/annaritmol.2015.4.2.
2. Chan V, Malas T, Lapierre H, et al. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation. 2011;124(11 Suppl):S75-80. doi:10.1161/CIRCULATIONAHA.110.011973.
3. Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg. 2009;87(5):1431-7; discussion 1437-9. doi:10.1016/j.athoracsur.2009.01.064.
4. Testa L, Popolo Rubbio A, Casenghi M, et al. Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era. J Am Heart Assoc. 2019;8(22):e013352. doi:10.1161/JAHA.119.013352.
5. Chiang YP, Chikwe J, Moskowitz AJ, et al. Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. Jama. 2014;312(13):1323-9. doi:10.1001/jama.2014.12679.
6. Kaneko T, Aranki S, Javed Q, et al. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J Thorac Cardiovasc Surg. 2014;147(1):117-26. doi:10.1016/j.jtcvs.2013.08.028.
7. Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148(5):2004-11.e1. doi:10.1016/j.jtcvs.2014.02.050.
8. Mehaffey HJ, Hawkins RB, Schubert S, et al. Contemporary outcomes in reoperative mitral valve surgery. Heart. 2018;104(8):652-6. doi:10.1136/heartjnl-2017-312047.
9. Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med. 2017;377(19):1847-57. doi:10.1056/NEJMoa1613792.
10. Jones JM, O’Kane H, Gladstone DJ, et al. Repeat heart valve surgery: risk factors for operative mortality. The J Thorac Cardiovasc Surg. 2001;122(5):913-8. doi:10.1067/mtc.2001.116470.
11. Maganti M, Rao V, Armstrong S, et al. Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009;87(2):521-5. doi:10.1016/j.athoracsur.2008.09.030.
12. Cheung A, Webb JG, Wong DR, et al. Transapical transcatheter mitral valve-invalve implantation in a human. Ann Thorac Surg. 2009;87(3):e18-20. doi:10.1016/j.athoracsur.2008.10.016.
13. Gallo M, Dvir D, Demertzis S, et al. Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves. Expert Rev Med Devices. 2016;13(8):749-58. doi:10.1080/17434440.2016.1207521.
14. Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40(5):441-51. doi:10.1093/eurheartj/ehy590.
15. Dvir D, Webb J. Mitral valve-in-valve and valve-in-ring: technical aspects and procedural outcomes. EuroIntervention. 2016;12(Y):Y93-6. doi:10.4244/EIJV12SYA25.
16. Wang DD, Eng MH, Greenbaum AB, et al. Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv. 2018;92(2):379-87. doi:10.1002/ccd.27447.
17. Guerrero M, Salinger M, Pursnani A, et al. Transseptal transcatheter mitral valve‐in‐valve: A step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv. 2018;92(3):E185-E196. doi:10.1002/ccd.27128.
18. Bogachev-Prokofiev AV, Zhuravleva IYu, Sharifulin RM, et al. In vitro implantation of the first domestic transcatheter prosthesis in the native mitral valve. Circulatory pathology and cardiac surgery. 22(1):22-8. (In Russ.) doi:10.21688/1681-3472-2018-1-22-28.
Review
For citations:
Bogachev-Prokofiev A.V., Sharifulin R.M., Ovcharov M.A., Pivkin A.N., Krestyaninov O.V., Antropova T.V., Ovchinnikova M.A., Astapov D.A., Sapegin A.V., Afanasyev A.V., Budagaev S.A., Zheleznev S.I. First experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis. Russian Journal of Cardiology. 2020;25(8):3847. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3847